Zoetis Inc. shares jumped 6.2% premarket Thursday after the animal health company reported fourth-quarter earnings that exceeded analyst expectations. The company posted adjusted earnings per share of $1.48, beating the consensus estimate of $1.40, while revenue reached $2.4 billion, surpassing the $2.36 billion forecast.

CEO Kristin Peck attributed the strong performance to leadership across key brands and categories, despite a dynamic operating environment. The company's International segment drove growth with revenue increasing 8% to $1.1 billion, while the U.S. segment revenue decreased 2% to $1.2 billion, though it remained flat on an organic operational basis.

For the full year 2025, Zoetis reported revenue of $9.5 billion, a 2% increase with organic operational growth of 6%. The company provided optimistic guidance for fiscal year 2026, projecting adjusted earnings per share between $7.00 and $7.10, above the consensus estimate of $6.82, with revenue expected between $9.825 billion and $10.025 billion.